Latest Reports

The “2023 Premium Cataract Surgery Market Report” is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2022 PCS manufacturer revenue, they are: the United States, China, South Korea, Japan, Brazil, Germany, Canada, Australia, France, India, Spain, the UK, and Italy.

For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities in each country for companies planning to market premium cataract surgery devices or looking to assess the value of each market.

Market Scope’s "2023 Retinal Disease Model" offers extensive country-level prevalence data and five-year forecasts for retinal diseases and conditions by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2023 Ophthalmic OR Microscopes Market Report” is a specialized supplement, expanding on the OR microscope section of Market Scope’s “2023 Ophthalmic Diagnostic Equipment Market Report.” The report is a leading industry source for information on all aspects of the global ophthalmic OR microscopes market. 

The report covers background information on the devices and groups estimates into three categories: basic microscope models, standard microscope models, and advanced microscope models. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

The “2023 Ophthalmic Laser Market Report” offers a comprehensive analysis of the global market for ophthalmic lasers, as well as a discussion of important trends and key factors shaping future success. The report covers photocoagulation, photodisruption, and SLT lasers with market data for 2022 and forecasts through 2028. Product demand is forecast in units and dollars, and market share is analyzed by product category.  Eighteen market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

This report is designed for ophthalmic industry manufacturers, market analysts, providers, and investors who are interested in the ophthalmic lasers business and related products. In-depth topics include laser treatment estimates, ophthalmic surgeons using lasers, and manufacturers of ophthalmic lasers (excluding femtosecond and excimer lasers).

Market Scope surveyed ophthalmologists and optometrists in the United States and Western Europe during July 2023 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.

Practitioners from most specialties (cataract, refractive, cornea, glaucoma, and comprehensive) who self-registered on Market-Scope.com were invited to participate in an annual sponsored survey on ocular surface disease.

An email invitation was sent on July 7, 2023, and last call invitations on July 14 and July 21, 2023. We received 169 total complete, unique responses – 130 from the US and 39 from Western Europe. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.

The “2023 United States Retina Atlas” provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing:

• Demographic information of selected metropolitan populations
• Profiles of selected metropolitan areas and applicable retinal treatment opportunity
• Current estimates for retinal surgery volume by metropolitan area
• Current estimates for retina surgeons by metropolitan area
• Comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies

The “2023 China Ophthalmic Market Report” covers all aspects of China’s ophthalmic market, providing a comprehensive overview of the Chinese population and economic conditions, discussing key strategic issues, studying disease prevalence, and analyzing surgical and therapeutic approaches, including both commercialized and pipeline products. The report analyzes unit demand and revenue, and forecasts future performance over the next five years. Competitor share is analyzed by product category and 32 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2023 US and Western Europe Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and Western Europe and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.

Market Scope’s “2022 European Five Ophthalmic Market Report” analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 11 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.

The “2022 United States Glaucoma Atlas” provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index Analysis™ analyzes market potential and provides a benchmark against other atlas metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.